RankAlpha logo
Back to Rankings

ROIV

Roivant SciencesF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Successful pivotal readouts or favorable regulatory outcomes derisk lead programs and trigger re-rating toward premium multiples and analyst highs.
Posture
Defensive
Lead driver
Value
What changed
3 setup hits (3d) with net bullish as of 2026-10-25.
What can break
Equity dilution / financing risk
Momentum
68
Value
41
Sentiment
24
Setup hits (3d)
3 · Net Bullish
AI TargetsBase $25.37 · Bull $32.98 · Bear $20.30Analysis 2026-02-07; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-07 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-10-23

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions

Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Bullish
Target $48.91
Why
Momentum68 · Δ7d -12.1
Value41 · Δ7d -0.1
Sentiment24 · Δ7d -6.3
So what
Weak posture (Net Bullish). Prioritize risk control and patience.

Confirming evidence

  • • 3 setup hits (3d) with net bullish as of 2026-10-25.
  • • Value remains the lead driver in the composite, 7D delta -0.1.

Contradictions & invalidation

  • • Equity dilution / financing risk
  • • Negative pivotal/late-stage clinical readout
  • • Failed or delayed readouts, weaker licensing outcomes, or financing pressure push valuation toward analyst lows and increase dilution risk.

Catalyst clock

2026-03-31

Analyst coverage refresh

Lead driver: Value · See fundamentals
Momentum
68
8% active weight
Current posture
7d trendSoftening
Δ7d
-12.1
Δ21d
-35.2
Value
41
47% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.4
Sentiment
24
45% active weight
Current posture
7d trendSoftening
Δ7d
-6.3
Δ21d
-5.1
Why this grade

Composite grade F. Momentum 68.2 / Value 40.6 / Sentiment 24.3

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-02-07. Scenario method

B+
Bull case
20%
Probability
Target price
$32.98
Analysis reference price unavailable
Analysis 2026-02-07 · RankAlpha Sentiment AI
Most likely
B
Base case
60%
Probability
Target price
$25.37
Analysis reference price unavailable
Analysis 2026-02-07 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$20.30
Analysis reference price unavailable
Analysis 2026-02-07 · RankAlpha Sentiment AI
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$26.36B
Beta
1.23
Shares Out
722.32M
P/E (TTM) · Derived
-84.5
P/S (TTM)
728.71
P/FCF (TTM) · Derived
-32.06
Rev YoY
-33.5%
EPS YoY
-19.8%
Gross Margin
+43.4%
Op Margin
-18146.1%
Net Debt
-$4.19B
Current Ratio
16.72
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data